These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 4814978

  • 21. The management of gout.
    Emmerson BT.
    Med J Aust; 1972 Mar 04; 1(10):475-8. PubMed ID: 5024419
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of benziodarone on hyperuricemia due to fasting].
    Fellin R, Pagnan A, Fedele D, Novello M, Crepaldi G.
    Policlinico Med; 1972 Mar 04; 79(3):151-64. PubMed ID: 5051107
    [No Abstract] [Full Text] [Related]

  • 23. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R, Bresnik W, Müller MM.
    Fortschr Med; 1979 Nov 22; 97(44):2057-61. PubMed ID: 511087
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Benziodarone in the treatment of primary hyperuricemias].
    Bianco G, Marcolongo R, Carcassi A.
    Minerva Med; 1968 Dec 12; 59(99):5470-81. PubMed ID: 5718835
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia].
    van Bogaert P.
    J Belge Rhumatol Med Phys; 1969 Dec 12; 24(6):295-315. PubMed ID: 5403086
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W, Zöllner N.
    Postgrad Med J; 1979 Dec 12; 55 Suppl 3():26-31. PubMed ID: 504037
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ.
    J Maine Med Assoc; 1979 Mar 12; 70(3):118-20, 122-7. PubMed ID: 374661
    [No Abstract] [Full Text] [Related]

  • 33. [Thyrotoxicosis and benzidarone].
    Camus JP, Prier A, Kartun P, Mauguélis de Bourguesdon.
    Rev Rhum Mal Osteoartic; 1973 Feb 12; 40(2):148-50. PubMed ID: 4705339
    [No Abstract] [Full Text] [Related]

  • 34. Gout and uric acid metabolism.
    Arthritis Rheum; 1970 Feb 12; 13(5):553-69. PubMed ID: 4922854
    [No Abstract] [Full Text] [Related]

  • 35. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
    Stamp LK, Haslett J, Frampton C, White D, Gardner D, Stebbings S, Taylor G, Grainger R, Kumar R, Kumar S, Kain T, Porter D, Corkill M, Cathro A, Metcalfe S, Wyeth J, Dalbeth N.
    Intern Med J; 2016 Sep 12; 46(9):1075-80. PubMed ID: 27391386
    [Abstract] [Full Text] [Related]

  • 36. Hyperuricemia and gout.
    Klinenberg JR.
    Med Clin North Am; 1977 Mar 12; 61(2):299-312. PubMed ID: 323595
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.